SLC2A12 Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q8TD20 |
---|---|
Other Accession | NP_660159.1 |
Clone Names | 91102072 |
Gene ID | 154091 |
---|---|
Other Names | Solute carrier family 2, facilitated glucose transporter member 12, Glucose transporter type 12, GLUT-12, SLC2A12, GLUT12, GLUT8 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | SLC2A12 (HGNC:18067) |
---|---|
Function | Insulin-independent facilitative glucose transporter. |
Cellular Location | Cell membrane {ECO:0000250|UniProtKB:Q8BFW9}; Multi-pass membrane protein. Endomembrane system {ECO:0000250|UniProtKB:Q5J316}; Multi-pass membrane protein. Cytoplasm, perinuclear region. Note=Localizes primarily perinuclear region in the absence of insulin. |
Tissue Location | Predominantly expressed in skeletal muscle, heart and prostate, with lower levels in brain, placenta and kidney |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
SLC2A12 belongs to a family of transporters that catalyzethe uptake of sugars through facilitated diffusion (Rogers et al.,2002). This family of transporters show conservation of 12transmembrane helices as well as functionally significant aminoacid residues (Joost and Thorens, 2001 [PubMed 11780753]).[suppliedby OMIM].
References
Stuart, C.A., et al. J. Clin. Endocrinol. Metab. 94(9):3535-3542(2009)Vieira, A.R., et al. Genet. Med. 10(9):668-674(2008)Stuart, C.A., et al. Am. J. Physiol. Endocrinol. Metab. 291 (5), E1067-E1073 (2006) :Linden, K.C., et al. Am. J. Physiol. Renal Physiol. 290 (1), F205-F213 (2006) :Rogers, S., et al. Biochem. Biophys. Res. Commun. 308(3):422-426(2003)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.